SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016504-15-000014
Filing Date
2015-11-05
Accepted
2015-11-05 15:08:15
Documents
11
Period of Report
2015-11-05

Document Format Files

Seq Description Document Type Size
1 inb10q_20150930.htm 10-Q 388627
2 exhibit31_1.htm EX-31.1 11050
3 exhibit31_2.htm EX-31.2 10829
4 exhibit32_1.htm EX-32.1 4527
5 exhibit32_2.htm EX-32.2 4459
  Complete submission text file 0001016504-15-000014.txt   3754720

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20150930.xml EX-101.INS 793772
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20150930.xsd EX-101.SCH 46299
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20150930_cal.xml EX-101.CAL 37212
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20150930_def.xml EX-101.DEF 307078
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20150930_lab.xml EX-101.LAB 265828
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20150930_pre.xml EX-101.PRE 323115
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 151200220
SIC: 2834 Pharmaceutical Preparations